Want to see GB:OPT full AI Analyst Report?
Top Page
Optima Health PLC
(LSE:OPT)
Select Model
Select Model
Rating:56Neutral
Price Target:
245.00 p
▲(15.84% Upside)
Action:Reiterated
Date:08/19/26
The score is driven primarily by improving financial performance (notably stronger cash flow and a return to profitability), supported by positive technical trend signals. These positives are materially offset by expensive valuation (high P/E) and financial risk from the sharp increase in leverage alongside still-thin margins.
Positive Factors
Revenue Recovery
Revenue returned to growth after two years of declines, indicating renewed demand or client activity. Although the recovery is not yet a long, steady trend, it gives the employer-services platform a stronger base for expansion.
Negative Factors
Higher Leverage
Debt rose more than fourfold year over year, materially increasing fixed financial obligations and reducing flexibility. If demand, margins or cash conversion weaken, higher leverage could constrain investment and amplify financial risk.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Recovery
Revenue returned to growth after two years of declines, indicating renewed demand or client activity. Although the recovery is not yet a long, steady trend, it gives the employer-services platform a stronger base for expansion.
Read all positive factors
Optima Health PLC (OPT) vs. iShares MSCI United Kingdom ETF (EWC)
Market Cap
£258.89M
Dividend YieldN/A
Average Volume (3M)135.53K
Price to Earnings (P/E)150.6
Beta (1Y)-0.17
Revenue Growth14.84%
EPS Growth-15.14%
CountryUK
Employees850
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)0.02
Shares Outstanding108,775,375
10 Day Avg. Volume155,484
30 Day Avg. Volume135,525
Financial Highlights & Ratios
PEG Ratio-2.23
Price to Book (P/B)0.95
Price to Sales (P/S)1.33
P/FCF Ratio12.18
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)0.14
Revenue Forecast (FY)£207.05M
Optima Health PLC Business Overview & Revenue Model
Company Description
Optima Health Plc specializes in delivering workplace health and employee wellbeing solutions. Their extensive range of offerings includes initiatives for engagement and overall wellness, alongside dedicated services for mental health and musculos...
How the Company Makes Money
Optima Health PLC makes money primarily by providing occupational health and employee wellbeing services to client organisations, typically employers. Revenue is generated from fees charged for delivering clinical and advisory services, which may ...
Optima Health PLC Financial Statement Overview
Summary
Income Statement
56
Neutral
Balance Sheet
49
Neutral
Cash Flow
62
Positive
| Breakdown | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 120.64M | 105.05M | 110.89M | 115.35M | 22.39M |
| Gross Profit | 26.56M | 33.04M | 36.47M | 36.94M | 8.04M |
| EBITDA | 15.18M | 13.65M | 10.06M | 11.06M | 1.74M |
| Net Income | 1.40M | 1.65M | -1.08M | 1.59M | -246.00K |
Balance Sheet | |||||
| Total Assets | 356.02M | 218.14M | 210.39M | 225.27M | 192.56M |
| Cash, Cash Equivalents and Short-Term Investments | 21.61M | 14.80M | 8.22M | 12.73M | 6.90M |
| Total Debt | 94.97M | 21.68M | 12.45M | 57.87M | 34.06M |
| Total Liabilities | 186.24M | 50.02M | 48.11M | 97.24M | 66.25M |
| Stockholders Equity | 169.78M | 168.12M | 127.62M | 128.03M | 126.31M |
Cash Flow | |||||
| Free Cash Flow | 13.19M | -1.06M | 10.00M | 2.40M | -1.63M |
| Operating Cash Flow | 14.28M | 2.69M | 12.85M | 6.59M | -836.00K |
| Investing Cash Flow | -104.95M | -5.65M | -2.85M | 843.00K | 7.77M |
| Financing Cash Flow | 97.48M | -3.33M | -1.63M | -1.61M | -205.00K |
Optima Health PLC Technical Analysis
Positive
211.50
Price Trends
215.64
Positive
201.50
Positive
198.51
Positive
Market Momentum
6.45
Positive
60.94
Neutral
26.07
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:OPT, the sentiment is Positive. The current price of 211.5 is below the 20-day moving average (MA) of 244.80, below the 50-day MA of 215.64, and above the 200-day MA of 198.51, indicating a neutral trend. The MACD of 6.45 indicates Positive momentum. The RSI at 60.94 is Neutral, neither overbought nor oversold. The STOCH value of 26.07 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for GB:OPT.
Optima Health PLC Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | £4.43B | 49.04 | 8.40% | 2.49% | 1.94% | -43.71% | |
72 Outperform | £610.26M | 61.04 | 3.87% | 1.68% | 28.96% | 39.58% | |
64 Neutral | £878.75M | 58.73 | 5.35% | 0.71% | 4.41% | -8.04% | |
64 Neutral | £943.56M | 57.33 | 2.22% | 0.67% | 4.54% | -34.92% | |
62 Neutral | £439.04M | 28.05 | 6.65% | 2.50% | 3.46% | 46.25% | |
56 Neutral | £258.89M | 150.63 | 0.83% | ― | 14.84% | -15.14% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
* Healthcare Sector Average
GB:OPT
Optima Health PLC
240.50
24.61
11.40%
GB:AMS
Advanced Medical Solutions
281.50
81.62
40.84%
GB:CTEC
ConvaTec
228.80
1.24
0.54%
GB:CRW
Craneware
1,272.00
-886.10
-41.06%
GB:CVSG
CVS Group plc
1,296.00
44.71
3.57%
GB:SPI
Spire Healthcare
237.00
12.53
5.58%
Optima Health PLC Corporate Events
Business Operations and StrategyFinancial DisclosuresM&A Transactions
Optima Health lifts revenue and margins as PAM deal cements UK occupational health lead
Positive
Aug 17, 2026
Optima Health PLC reported a strong FY26 performance, with revenue rising 14.8% to £120.6 million and adjusted EBITDA up to £20.1 million, in line with expectations and ahead of prior guidance on profit. The company maintained its adjust...
Business Operations and StrategyFinancial Disclosures
Optima Health Sets Date for Full‑Year Results and Analyst Briefing
Neutral
Aug 10, 2026
Optima Health plc, the UK’s leading provider of technology‑enabled occupational health and wellbeing services, will publish its unaudited full‑year results for the period ended 31 March 2026 on 17 August 2026. The Group serves mi...
Business Operations and StrategyFinancial DisclosuresM&A TransactionsPrivate Placements and Financing
Optima Health lifts revenue 15% and boosts outlook after £100m PAM acquisition
Positive
Jun 16, 2026
Optima Health reported unaudited full-year revenue of about £121 million for the year to 31 March 2026, a 15% increase and in line with market expectations, with adjusted EBITDA anticipated to come in roughly 10% above prior forecasts. The co...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.